NRC Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $21.93
Capitalización Bursátil (MRQ) $486M
P/E (TTM) 0.4
BPA (TTM) $49.75
Ingresos (TTM) $140M
ROE (TTM) 42.0%
Deuda/Capital (MRQ) 14.4
Rango 52S $11–$24

NRC Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Acerca de National Research Corporation - Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.

History

National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.

In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.

In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.

The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.

In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.

In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.

In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.

On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.

Awards

NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.

In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.

In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.

Products and services

Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.

Under this strategy, the company provides:

Patient & Family Experience

Resident & Family Experience

Employee Engagement

Physician Engagement

The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program

Market Insights

Healthcare Analytics

Clinical & Outcomes Analytics

Health Risk Assessments

Patient Outreach Programs

Integrated Solutions

The Institutes

CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealth Care industriaHealth Care empleados357 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$137M
2016-12-31 → 2025-12-31
BPA$50.00
2019-12-31 → 2025-12-31
Flujo de caja libre·
2016-12-31 → 2024-12-31
Margen neto4.2%
2016-12-31 → 2024-12-31
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años NRC promedio 5A Mediana de Pares Veredicto
P/E (TTM) 0.4promedio 5A ≈21.4 ≈21.4 18.9 Infravalorado
P/S (TTM) 3.5promedio 5A ≈5.6 ≈5.6 1.7 Sobrevalorado
P/C (MRQ) 74.1promedio 5A ≈14.4 ≈14.4 3.0 Sobrevalorado
Precio / FCF (TTM) 22.4promedio 5A ≈31.2 ≈31.2 · ·
Precio / Flujo de Caja (TTM) 16.5promedio 5A ≈21.2 ≈21.2 · ·
Precio / Valor Contable Tangible (MRQ) 109.2 · · ·
PEG Ratio (Ratio PEG) ≈0.0 · · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

13
Pago anualizado≈$0.64Pago trimestral
Racha de Crecimiento≈1Años consecutivos de crecimiento de dividendos
Fecha ex-dividendoMontoMonedaRendimiento
Sep 25, 2026$0,16USD≈3.3%
Jun 26, 2026$0,16USD≈2.9%
Mar 27, 2026$0,16USD≈3.3%
Dic 26, 2025$0,16USD≈2.8%
Sep 26, 2025$0,12USD≈3.6%
Jun 27, 2025$0,12USD≈2.9%
Mar 28, 2025$0,12USD≈3.7%
Dic 27, 2024$0,12USD≈2.8%
Sep 27, 2024$0,12USD≈2.1%
Jun 28, 2024$0,12USD≈6.4%
Mar 27, 2024$0,12USD≈3.8%
Dic 28, 2023$0,12USD≈3.8%
Sep 28, 2023$0,12USD≈3.9%
Sep 15, 2023$1,00USD≈3.5%
Jun 29, 2023$0,12USD≈1.4%
Mar 30, 2023$0,12USD≈1.7%
Dic 29, 2022$0,12USD≈2.3%
Sep 29, 2022$0,24USD≈2.1%
Jun 29, 2022$0,24USD≈1.9%
Mar 30, 2022$0,24USD≈1.5%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media 44.0%
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Jul 27, 2026 $0.31 $0.14 119.2%
31 de marzo de 2026 $0.21 — —
31 de diciembre de 2025 $0.16 — —
30 de septiembre de 2025 $0.23 — —
30 de junio de 2019 $0.29 $0.26 10.4%
31 de marzo de 2019 $0.32 $0.31 2.2%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 15
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue $137M$143M$149M$152M$148M$133M$128M$120M$118M$109M$102M$99M
SG&A Expense $55M$45M$47M$43M$39M$34M$33M$31M$30M$28M$27M$25M
Operating Expenses $115M$108M$109M$105M$98M$91M$85M$84M$83M$78M$76M$71M
Operating Income $23M$35M$40M$47M$50M$43M$43M$35M$34M$31M$26M$28M
Interest Expense ·$3M$862.0K$1M$2M$2M$2M$2M$82.0K$190.0K$220.0K$305.0K
Interest Income $111.0K$125.0K$820.0K$168.0K$14.0K$18.0K$37.0K$62.0K$96.0K$47.0K$60.0K$83.0K
Other Non-op $-95.0K$-34.0K$-41.0K$-118.0K$4.0K$585.0K$-462.0K$885.0K$50.0K$302.0K$1M$18.0K
Pretax Income $18M$33M$40M$43M$49M$41M$41M$35M$34M$31M$27M$28M
Income Tax $6M$8M$9M$11M$11M$4M$8M$5M$11M$11M$10M$10M
Net Income $12M$25M$31M$32M$37M$37M$32M$30M$23M$21M$18M$18M
EPS (Basic) $50.00$1.05$1.26$1.28$1.47$1.48$1.30·····
EPS (Diluted) $50.00$1.04$1.25$1.27$1.46$1.45$1.26·····
Shares (Basic) 22,383,00023,703,00024,540,00024,922,00025,422,00025,170,00024,809,000·····
Shares (Diluted) 22,396,00023,743,00024,673,00025,052,00025,640,00025,696,00025,653,000·····
EBITDA ·$35M$40M$47M$50M·$43M$35M$34M$31M$26M$32M
Balance general 29
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents $4M$4M$7M$25M$54M$35M$14M$13M$35M$33M$42M$40M
Receivables $11M$11M$12M$14M$14M$14M$12M$12M$15M$11M$10M$8M
Prepaid Expense $4M$3M$4M$2M$4M$3M$2M$3M$2M$2M$1M$1M
Other Current Assets $520.0K$692.0K$940.0K$1M$982.0K$2M$2M$224.0K$35.0K$35.0K$34.0K$994.0K
Current Assets $20M$20M$24M$44M$74M$54M$29M$28M$52M$47M$55M$53M
PP&E (Net) ·$38M$28M$17M$12M$12M$14M$14M$12M$12M$11M$12M
PP&E (Gross) ·$74M$64M$51M$46M$43M$42M$45M$40M$38M$35M$35M
Accum. Depreciation ·$35M$36M$34M$33M$31M$29M$31M$28M$26M$23M$23M
Goodwill $66M$66M$62M$62M$62M$57M$58M$58M$58M$58M$58M$58M
Intangibles $2M$3M$1M$2M$2M$1M$2M$2M$3M$3M$4M$5M
Other Non-current Assets $3M$4M$3M$3M$3M$3M$3M$2M$2M$768.0K$293.0K$234.0K
Total Assets $135M$133M$122M$130M$158M$133M$111M$108M$127M$121M$128M$130M
Accounts Payable $1M$1M$1M$1M$2M$1M$1M$613.0K$593.0K$765.0K$614.0K$830.0K
Accrued Liabilities $3M$5M$5M$4M$5M$3M$3M$3M$3M$3M$3M$3M
Short-term Debt $4M$5M$7M$4M$4M$4M$4M$4M$1M$3M$2M$2M
Current Liabilities $37M$36M$36M$33M$40M$32M$38M$47M$32M$32M$44M$28M
Capital Leases $744.0K$1M$2M····$676.0K$87.0K$110.0K$103.0K$167.0K
Deferred Tax $6M$4M$4M$5M$7M$7M$7M$6M$4M$5M$6M$7M
Other Non-current Liabilities $3M$4M$4M$2M$3M$4M$2M$1M$935.0K$777.0K$575.0K$541.0K
Total Liabilities $121M$101M$73M$58M$72M$69M$78M$89M$37M$38M$54M$42M
Long-term Debt $79M·$37M$22M$27M$31M$34M$38M$1M$4M$6M$8M
Total Debt ·$63M$7M$4M$4M·$34M$38M$2M$6M$8M$10M
Common Stock $32.0K$31.0K$31.0K$31.0K$31.0K$31.0K$30.0K$30.0K$26.0K···
Retained Earnings $-17M$-17M$-31M$-25M$-36M$-61M$-93M$-106M$78M$72M$65M$74M
Treasury Stock $153M$132M$99M$78M$50M$44M$34M$29M$37M$33M$32M$30M
AOCI ·········$-3M$-3M$-773.0K
Stockholders' Equity $14M$31M$49M$72M$85M$64M$33M$19M$90M$83M$74M$88M
Liabilities + Equity $135M$133M$122M$130M$158M$133M$111M$108M$127M$121M$128M$130M
Shares Outstanding 22,637,25223,083,11624,219,88724,628,17325,361,40925,390,96824,947,50024,800,79620,936,703···
Flujo de Efectivo 16
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A $8M$6M$6M···$6M$5M$5M$4M$4M$4M
Stock-based Comp $3M$284.0K$935.0K$1M$623.0K$680.0K$1M$2M$2M$2M$1M$742.0K
Deferred Tax $2M$-664.0K$-1M$-2M$-277.0K$-134.0K$1M$1M$-684.0K$798.0K$-1M$107.0K
Amort. of Intangibles $389.0K$264.0K$140.0K$180.0K$320.0K$318.0K$374.0K$662.0K$610.0K$654.0K$995.0K$876.0K
Other Non-cash ···········$3M
Operating Cash Flow $26M$35M$38M$36M$46M$41M$41M$40M$28M$27M$22M$26M
CapEx $11M$15M$16M$10M$6M$4M$5M$6M$5M$4M$3M$2M
Investing Cash Flow $-11M$-20M$-16M$-10M$-9M$-4M$-5M$-6M$-6M$-4M$-1M$-6M
Stock Repurchased $20M$31M$19M$28M$4M·····$2M·
Net Stock Activity ·$-31M$-19M$-28M$-4M·····$-2M·
Dividends Paid $11M$11M$36M$21M$9M$11M$31M$17M$17M$29M$10M·
Financing Cash Flow $-16M$-17M$-41M$-56M$-18M$-16M$-36M$-54M$-21M$-33M$-17M$-2M
Net Change in Cash $-94.0K$-2M$-18M$-29M$20M$21M$526.0K$-22M$2M$-9M$2M$18M
Taxes Paid ·$8M$9M$12M$11M$5M$7M$3M$13M$10M$9M·
Free Cash Flow ·$19M$22M$26M$41M·$36M$34M$24M$23M$19M$24M
Levered FCF ·$17M$22M$26M$40M·$35M$33M$23M$23M$19M$24M
Rentabilidad 7
Métrica Tendencia 202520242023202220212020201920182017201620152014
Operating Margin ·24.6%27.0%30.7%34.0%·33.6%29.5%29.1%28.5%25.8%28.6%
Net Margin ·17.3%20.8%21.0%25.3%·25.3%25.1%19.5%18.8%17.2%18.4%
Pretax Margin ·22.9%26.9%28.2%32.9%·31.7%29.0%29.2%28.7%26.7%28.4%
EBITDA Margin ·24.6%27.0%30.7%34.0%·33.6%29.5%29.1%28.5%25.8%32.5%
ROA ·19.4%24.5%22.1%25.8%·29.6%25.5%18.5%16.5%13.6%15.1%
ROE ·75.2%58.0%45.5%44.5%·104.8%122.1%26.6%26.1%21.7%22.8%
ROIC ·28.4%55.2%45.2%43.2%·51.3%53.6%24.8%22.9%20.7%18.6%
Liquidez y Solvencia 5
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio ·0.50.71.31.8·0.80.61.61.51.31.9
Quick Ratio ·0.40.51.21.7·0.70.51.51.41.21.7
Debt / Equity ·2.00.10.10.1·1.02.00.00.10.10.1
LT Debt / Equity ·1.9····0.91.8·0.00.00.1
Interest Coverage ·13.646.538.530.2·20.623.3417.3164.2120.292.8
Eficiencia 2
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover ·1.11.21.11.0·1.21.00.90.90.80.8
Receivables Turnover ·12.211.110.810.7·10.99.09.710.611.410.3
Por Acción 6
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share ·$1.36$2.02$2.92$3.36·$1.32$0.77····
Revenue / Share ·$6.03$6.02$6.05$5.77·······
Cash Flow / Share ·$1.46$1.54$1.45$1.81·······
Cash / Share ·$0.18$0.27$1.02$2.14·$0.54$0.52····
Dividend / Share $0.52$0.48$1.48$0.84$0.48$0.21$0.78·····
EPS (TTM) $50.00$1.04$1.25$1.27$1.46$1.45$1.26$2.28$2.28$2.28$2.28$2.28
Tasas de Crecimiento 10
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY -4.0%-3.7%-2.0%2.4%11.0%·······
Revenue CAGR 3Y -3.2%-1.1%3.7%·········
Revenue CAGR 5Y 0.61%···········
EPS YoY 4707.7%-16.8%-1.6%-13.0%0.69%·······
EPS CAGR 3Y 240.2%-10.7%-4.8%·········
EPS CAGR 5Y 103.0%···········
Net Income YoY -53.2%-20.0%-2.6%-15.1%0.55%·······
Net Income CAGR 3Y -28.5%-12.9%-6.0%·········
Net Income CAGR 5Y -20.8%···········
Dividends Paid CAGR 5Y 0.86%···········
Valoración (TTM) 17
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM $137M$143M$149M$152M$148M$133M$128M$120M$118M$109M$102M$99M
Net Income TTM $12M$25M$31M$32M$37M$37M$32M$30M$23M$21M$18M$18M
Market Cap ·$407M$958M$919M$1.05B·$1.65B$946M····
Enterprise Value ·$466M$959M$898M$1.00B·$1.67B$971M····
P/E 0.417.031.629.428.429.552.316.716.48.37.06.1
P/S ·2.86.46.17.1·12.97.9····
P/B ·13.019.612.812.3·50.049.6····
P / Tangible Book ···104.348.0192.1······
P / Cash Flow ·11.825.125.322.7·40.223.7····
P / FCF ·21.242.934.825.8·45.427.9····
EV / EBITDA ·13.223.919.320.0·38.727.5····
EV / FCF ·24.342.934.024.6·45.928.7····
EV / Revenue ·3.36.55.96.8·13.08.1····
Dividend Yield ·2.8%3.8%2.3%0.87%·1.9%1.8%····
Earnings Yield 266.4%5.9%3.2%3.4%3.5%3.4%1.9%6.0%6.1%12.0%14.2%16.3%
Payout Ratio ·46.2%117.4%65.9%24.4%·96.6%56.1%73.5%139.2%57.1%·
Annual Payout $11M$11M$36M$21M$9M$11M$31M$17M$17M$29M$10M·

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $137M $143M $149M $152M $148M
Margen Operativo % · 24.6% 27.0% 30.7% 34.0%
Beneficio neto $12M $25M $31M $32M $37M
EPS Diluido $50.00 $1.04 $1.25 $1.27 $1.46

Propietarios institucionales (13F) 135 declarantes · $248.4M total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 135
Valor en tenencia $248.4M
Nuevas posiciones 18
Posiciones cerradas 11
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
18 (-1 vs trimestre anterior) 11 (+1 vs trimestre anterior) 43 (+14 vs trimestre anterior) 39 (-15 vs trimestre anterior) -77K

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $43 797 714 2 030 492 17,63% Acciones
BlackRock, Inc. $22 893 428 1 061 355 9,22% Acciones
MORGAN STANLEY $18 534 465 859 269 7,46% Acciones
VANGUARD GROUP INC $15 604 984 831 379 6,28% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $14 377 570 666 554 5,79% Acciones
FARMERS & MERCHANTS INVESTMENTS INC $10 631 680 501 731 4,28% Acciones
DIMENSIONAL FUND ADVISORS LP $10 595 956 491 228 4,27% Acciones
Willis Investment Counsel $9 132 593 430 986 3,68% Acciones
GEODE CAPITAL MANAGEMENT, LLC $9 062 880 420 056 3,65% Acciones
QV Investors Inc. $7 893 000 372 503 3,18% Acciones
RENAISSANCE TECHNOLOGIES LLC $7 018 533 325 384 2,83% Acciones
STATE STREET CORP $6 483 381 298 384 2,61% Acciones
HEARTLAND ADVISORS INC $6 471 000 300 000 2,61% Acciones
Bank of New York Mellon Corp $5 440 710 252 235 2,19% Acciones
NORTHERN TRUST CORP $5 138 900 238 243 2,07% Acciones
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $4 053 434 187 920 1,63% Acciones
WELLS FARGO & COMPANY/MN $3 874 460 179 623 1,56% Acciones
AQR CAPITAL MANAGEMENT LLC $2 635 976 122 206 1,06% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2 444 140 113 312 0,98% Acciones
Northwest & Ethical Investments L.P. $2 208 121 102 370 0,89% Acciones
VANGUARD FIDUCIARY TRUST CO $2 096 604 97 200 0,84% Acciones
GOLDMAN SACHS GROUP INC $2 087 458 96 776 0,84% Acciones
JANE STREET GROUP, LLC $1 884 679 87 375 0,76% Acciones
FIFTH THIRD BANCORP $1 841 475 85 372 0,74% Acciones
BANK OF AMERICA CORP /DE/ $1 789 145 82 946 0,72% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $1 762 808 81 725 0,71% Acciones
COMERICA BANK $1 687 723 89 916 0,68% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $1 675 644 77 684 0,67% Acciones
Linden Thomas Advisory Services, LLC $1 639 958 77 393 0,66% Acciones
Quantinno Capital Management LP $1 577 892 73 152 0,64% Acciones
CITADEL ADVISORS LLC $1 382 529 64 095 0,56% Acciones
TWO SIGMA INVESTMENTS, LP $1 357 573 62 938 0,55% Acciones
ENVESTNET ASSET MANAGEMENT INC $1 354 184 62 781 0,55% Acciones
SEI INVESTMENTS CO $1 027 834 47 651 0,41% Acciones
ALPS ADVISORS INC $1 015 365 47 073 0,41% Acciones
Williams Jones Wealth Management, LLC. $901 626 41 800 0,36% Acciones
AMERICAN CENTURY COMPANIES INC $831 847 38 565 0,33% Acciones
Squarepoint Ops LLC $798 112 37 001 0,32% Acciones
US BANCORP \DE\ $715 175 33 156 0,29% Acciones
Nuveen, LLC $653 959 30 318 0,26% Acciones
HSBC HOLDINGS PLC $634 793 29 539 0,26% Acciones
Daiwa Securities Group Inc. $629 218 29 171 0,25% Acciones
Creative Planning $624 487 28 952 0,25% Acciones
MARSHALL WACE, LLP $502 193 23 282 0,20% Acciones
Empirical Finance, LLC $431 400 20 000 0,17% Acciones
Invesco Ltd. $429 847 19 928 0,17% Acciones
Cove Street Capital, LLC $417 063 32 634 0,17% Acciones
OSAIC HOLDINGS, INC. $389 338 18 050 0,16% Acciones
AMERIPRISE FINANCIAL INC $366 928 17 007 0,15% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $351 591 16 300 0,14% Opción de venta

Mostrar todos los 135 propietarios institucionales →

Activistas y propietarios del %+ 5 6 tenencias

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 presentaciones 12 de junio de 2026 45,70% Enmienda · SEC
Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 presentaciones 5 de marzo de 2024 · Presentación inicial · SEC
Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 presentaciones 4 de enero de 2024 · Presentación inicial · SEC
Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 15 de marzo de 2021 · Presentación inicial · SEC
Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) 25 de abril de 2018 · Presentación inicial · SEC
Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 14 de junio de 2013 · Presentación inicial Inversión pasiva SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 27 insiders · 13 directivos · 11 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Trent S Green Chief Executive Officer 1 de junio de 2025 A 500 000 0 0 $0
Shane R Harrison EVP & Chief Financial Officer 17 de febrero de 2026 P 8 000 1 0 $98 160
Kevin R Karas SVP Finance, CFO, Treas & Secy 28 de febrero de 2023 S 5 384 0 0 $0
Steven D. Jackson President 1 de octubre de 2020 F 55 567 0 0 $0
Susan L Henricks President and COO 7 de enero de 2014 A 7 823 0 0 $0
Joseph W Carmichael President 9 de mayo de 2008 F 41 872 0 0 $0
Helen Hrdy EVP & Chief Operating Officer 15 de diciembre de 2025 M 140 518 0 0 $0
Jona S Raasch COO, NRC Health 3 de abril de 2023 S 1 688 0 0 $0
Jason Russell Rau Executive Vice President 12 de marzo de 2026 A 60 000 0 0 $0
David Burik EVP, Strategic Insights 5 de enero de 2026 A 100 000 0 0 $0
Hays Michael D. Chairman 5 de enero de 2026 M 20 154 0 0 $0
Jordan Nicole Freeman Chief Accounting Officer 31 de julio de 2025 P 771 0 0 $0
Andrew Monnich Chief Corp. Development Off. 7 de abril de 2025 A 100 000 0 0 $0
Parul Bhandari Consejero 23 de junio de 2026 A 7 697 0 0 $0
Penny Ann Wheeler Consejero 23 de junio de 2026 A 7 697 0 0 $0
Stephen H Lockhart Consejero 23 de junio de 2026 A 7 697 0 0 $0
Donald M Berwick Consejero 23 de junio de 2026 A 7 697 0 0 $0
John N Nunnelly Consejero 23 de junio de 2026 A 40 363 0 0 $0
Joann M Martin Consejero 29 de junio de 2021 A 138 955 0 0 $0
Barbara Mowry Consejero 15 de mayo de 2020 M 42 902 0 0 $0
Gail L Warden Consejero 9 de mayo de 2017 A 10 263 0 0 $0
Paul C Schorr III Consejero 28 de octubre de 2013 G 34 802 0 0 $0
Beans Patrick E. Propietario del 10% 12 de mayo de 2025 P 35 003 0 0 $0
Common Property Trust Propietario del 10% 31 de diciembre de 2024 G 4 755 317 0 0 $0
Amandla MK Trust Propietario del 10% 31 de diciembre de 2024 G 0 0 0 $0
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 Propietario del 10% 11 de marzo de 2021 S 0 0 0 $0
Karen S Hays Propietario del 10% 12 de febrero de 2010 G 0 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 21 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
ROSC · Lattice Strategies Trust 0,38% 12 032 NS 31 de julio de 2026 N-PORT
IWC · iShares Trust 0,06% 40 256 SH 11 de septiembre de 2026 Diario
IWO · iShares Trust 0,02% 111 072 SH 11 de septiembre de 2026 Diario
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 12 922 SH 23 de octubre de 2026 Diario
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 68 097 SH 19 de agosto de 2026 Diario
VTWG · VANGUARD SCOTTSDALE FUNDS 0,01% 12 633 SH 19 de agosto de 2026 Diario
IWM · iShares Trust 0,01% 301 953 SH 11 de septiembre de 2026 Diario
DFAS · Dimensional ETF Trust 0,01% 62 228 NS 31 de julio de 2026 N-PORT
RSSL · Global X Funds 0,01% 5 634 NS 31 de julio de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,00% 560 NS 31 de julio de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 2 149 NS 31 de julio de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 1 985 NS 31 de julio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 17 485 NS 31 de julio de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 4 118 NS 31 de julio de 2026 N-PORT
ITOT · iShares Trust 0,00% 23 452 SH 11 de septiembre de 2026 Diario
IWV · iShares Trust 0,00% 3 867 SH 3 de septiembre de 2026 Diario
DFUS · Dimensional ETF Trust 0,00% 2 478 NS 31 de julio de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 151 126 SH 19 de agosto de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,00% 498 279 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 995 SH 19 de agosto de 2026 Diario
SMLF · iShares Trust · 66 767 SH 11 de septiembre de 2026 Diario

NRC Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 5 analistas COMPRA
Objetivo mediano $26.00 +18,6%
1 20,0% Compra fuerte
3 60,0% Compra
1 20,0% Mantener
0 0,0% Venta
0 0,0% Venta fuerte

Precio objetivo a 12 meses

1 analistas · 2026-10-25

Objetivo medio $26.00 +18,6%

Mín$26.00 Media$26.00 Máx$26.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
NRC · 0.4 -4.0% · · ·
FLGT $816M -84.7 13.8% -18.8% -5.4% 40.6%
SBC · · · · · ·
SRTA · · · · · ·
VMD $282M 20.1 20.5% 5.5% 10.9% 57.5%
BDSX $56M -1.5 24.1% -39.9% 5315.0% ·
CVS $100.87B 57.1 7.8% 0.44% 2.4% ·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Ago 4, 2026